http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Premier Protein® Fuels New Year, New You Goals with Expanded High-Protein Breakfast Line
-
Bitget Crosses $1B Tokenized Stock Spot Volume Amid 4,900% Spike in Tokenized Gold Trading
-
New AI Platform Launches to Combat $28 Billion Scam Economy Targeting Seniors
-
American Antimony Corp. Executes First MTA Milestone with Delivery of 400 kg of Nevada-Sourced High-Grade Antimony Ore
-
Capstone Green Energy to Power First-of-Its-Kind 6.6MW Biogas Project at Renewable Energy Facility in North Carolina
-
Volunteer Advocates Mobilize Nationwide to Urge Lawmakers to Support State-level Suicide Prevention Policies
-
Jeanne D'Arc Credit Union Partners With Alacriti for a Multi-Year Modernization Strategy Around Real-Time Payments
-
Lamperd Less Lethal Receives Initial Order with Deposit Towards Major Non-Lethal Product Production Run Valued at $780,000 USD for Middle East Police Services Customer
-
Rapid Micro Biosystems to Present at 44th Annual J.P. Morgan Healthcare Conference
-
Metrie Celebrates 100 Years: A Century of Gratitude, Family Values, and Shared Success
-
Siren Biotechnology to Showcase Clinical-Stage Momentum at Major 2026 Healthcare Conferences
-
Sanford Heisler Sharp McKnight Promotes Two Lawyers to Partnership and Two Lawyers to Senior Litigation Counsel
-
Ainos partners with Trusval for semiconductor AI nose distribution
-
Ainos Announces Distribution Partnership with Trusval Technology to Expand AI Nose into Semiconductor Front-End Manufacturing
-
Fraser Health Saves 7 Minutes Per Patient in Discharge Time with MEDITECH’s AI-Powered Hospital Course Summary
-
IMAX Closes Out Best Year in its History with Record $1.28 Billion at the Global Box Office in 2025
-
Blackstone Mortgage Trust Announces Fourth-Quarter and Full-Year 2025 Earnings Release and Conference Call
-
Foresight: Eye-Net to Showcase its Innovative V2X Collision Prevention Technology at CES 2026 in Las Vegas
-
Exelixis and Natera partner on phase 3 colorectal cancer trial
-
Exelixis and Natera to Collaborate on STELLAR-316, a Phase 3 Pivotal Trial of Zanzalintinib for Patients with Colorectal Cancer
-
AbbVie to Host Full-Year and Fourth-Quarter 2025 Earnings Conference Call
-
Blackstone Announces Additional Investment in AIR Control Concepts
-
Arrowhead receives China approval for rare disease drug REDEMPLO
-
Palvella Therapeutics Strengthens Leadership Team with Appointment of Veteran Medical Affairs Leader Vimal Patel, PharmD, as Senior Vice President of Medical Affairs
-
Arrowhead Pharmaceuticals Announces NMPA Approval of REDEMPLO® (plozasiran) for Familial Chylomicronemia Syndrome (FCS) in China
-
TG Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
-
Thermal Energy promotes Vincent Sands to executive vice president
-
Thermal Energy Appoints Vincent Sands as Executive Vice President
-
BitMart Exchange Announces Partnership with Hit TV-Reality Show CryptoKnights for Season 2
-
ABBYY and Desktop Imaging Fully Automate New Zealand Citizen Services and Enable Frontline Emergency Teams to Focus on Critical Work with Document AI
-
Clarence Stream Drilling Intersects 2.6 g/t Gold Over 16.0m Including 6.2 g/t Over 5.0m at Southwest Deposit
-
Genprex Provides Clinical Update on Diabetes Gene Therapy Program
-
Surge Welcomes OEM Lithium Expert to NNL Leadership
-
Aprio Expands in Pacific Northwest, Uniting Two Leading Oregon Firms - Delap LLP and Hoffman, Stewart & Schmidt, P.C.
-
Ping Identity Marks Digital Trust Milestone with Zero-Knowledge Biometrics in the Age of AI
-
Merck starts phase 3 trial of KRAS G12C inhibitor with KEYTRUDA QLEX
-
Merck Initiates Phase 3 KANDLELIT-007 Trial Evaluating Calderasib (MK-1084), an Investigational Oral KRAS G12C Inhibitor, in Combination With KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa
-
Merck to Complete Acquisition of Cidara Therapeutics
-
Merck to Hold Fourth-Quarter and Full-Year 2025 Sales and Earnings Conference Call Feb. 3
-
Bitget Opens TradFi Trading to All Users After Record-Breaking Beta Demand
-
Golden Cariboo Summarizes 2025 Mineral Exploration at the Quesnelle Gold Quartz Mine Property
-
GSK hepatitis B drug meets goals in phase 3 trials
-
Ionis partner GSK announces positive topline results from B-Well 1 and B-Well 2 Phase 3 studies for bepirovirsen, a potential first-in-class medicine for chronic hepatitis B
-
Dreame Debuts Revolutionary Hair Care Lineup at CES 2026: AI-Powered Pilot 20 Hair Dryer Features Dual Robotic Arms for Proactive Care
-
Professional Imaging, Thumb-Sized: Dreame Introduces the LEAPTIC Cube, Its First 8K AI Action Camera at CES 2026
-
Dreame Technology to Unveil Its Whole-Home Smart Ecosystem of Breakthrough Technologies at CES 2026 with "All Dreams in One Dreame" Vision
-
All Dreams in One Dreame at CES 2026: Dreame Technology Unveils X60 Ultra Series Alongside Industry-First Innovations to Redefine Smart Cleaning
-
World Wide Technology Unveils ARMOR: A Collaborative AI Security Framework with NVIDIA AI
-
Exelixis to Present at the J.P. Morgan 2026 Healthcare Conference on January 12, 2026
-
Coalfire Appoints Brad Little as Chief Executive Officer
